Large differences in collateral blood vessel abundance among individuals arise from multiple genetic variants.


Journal

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
ISSN: 1559-7016
Titre abrégé: J Cereb Blood Flow Metab
Pays: United States
ID NLM: 8112566

Informations de publication

Date de publication:
11 2023
Historique:
medline: 9 11 2023
pubmed: 13 8 2023
entrez: 12 8 2023
Statut: ppublish

Résumé

Collateral blood flow varies greatly among humans for reasons that remain unclear, resulting in significant differences in ischemic tissue damage. A similarly large variation has also been found in mice that is caused by genetic background-dependent differences in the extent of collateral formation, termed collaterogenesis-a unique angiogenic process that occurs during development and determines collateral number and diameter in the adult. Previous studies have identified several quantitative trait loci (QTL) linked to this variation. However, understanding has been hampered by the use of closely related inbred strains that do not model the wide genetic variation present in the "outbred" human population. The Collaborative Cross (CC) multiparent mouse genetic reference panel was developed to address this limitation. Herein we measured the number and average diameter of cerebral collaterals in 60 CC strains, their 8 founder strains, 8 F1 crosses of CC strains selected for abundant versus sparse collaterals, and 2 intercross populations created from the latter. Collateral number evidenced 47-fold variation among the 60 CC strains, with 14% having poor, 25% poor-to-intermediate, 47% intermediate-to-good, and 13% good collateral abundance, that was associated with large differences in post-stroke infarct volume. Collateral number in skeletal muscle and intestine of selected high- and low-collateral strains evidenced the same relative abundance as in brain. Genome-wide mapping demonstrated that collateral abundance is a highly polymorphic trait. Subsequent analysis identified: 6 novel QTL circumscribing 28 high-priority candidate genes harboring putative loss-of-function polymorphisms (SNPs) associated with low collateral number; 335 predicted-deleterious SNPs present in their human orthologs; and 32 genes associated with vascular development but lacking protein coding variants. Six additional suggestive QTL (LOD > 4.5) were also identified in CC-wide QTL mapping. This study provides a comprehensive set of candidate genes for future investigations aimed at identifying signaling proteins within the collaterogenesis pathway whose variants potentially underlie genetic-dependent collateral insufficiency in brain and other tissues.

Identifiants

pubmed: 37572089
doi: 10.1177/0271678X231194956
pmc: PMC10676139
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1983-2004

Subventions

Organisme : NIAID NIH HHS
ID : P01 AI132130
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS083633
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI100625
Pays : United States

Commentaires et corrections

Type : UpdateOf

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

J Cereb Blood Flow Metab. 2010 May;30(5):923-34
pubmed: 20125182
J Cereb Blood Flow Metab. 2021 Feb;41(2):397-412
pubmed: 32241204
Circ Res. 2021 Feb 5;128(3):363-382
pubmed: 33301355
Angiogenesis. 2015 Jul;18(3):265-81
pubmed: 25862671
Circ Res. 2010 Aug 20;107(4):558-68
pubmed: 20576932
Int J Mol Sci. 2017 Dec 09;18(12):
pubmed: 29232823
Mamm Genome. 2015 Oct;26(9-10):521-39
pubmed: 26135136
J Cereb Blood Flow Metab. 2021 Aug;41(8):2067-2075
pubmed: 33557694
J Cereb Blood Flow Metab. 2021 Nov;41(11):3039-3051
pubmed: 34112002
Stroke. 2016 Dec;47(12):3022-3031
pubmed: 27811335
J Cell Biol. 2004 Feb 2;164(3):451-9
pubmed: 14745002
J Biol Chem. 2018 Mar 30;293(13):4805-4817
pubmed: 29425100
Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):1854-9
pubmed: 25012127
J Cereb Blood Flow Metab. 2021 Oct;41(10):2676-2689
pubmed: 33899558
Transl Stroke Res. 2019 Apr;10(2):189-203
pubmed: 29589286
Front Cardiovasc Med. 2022 Mar 22;9:778773
pubmed: 35391845
Nucleic Acids Res. 2003 Jul 1;31(13):3812-4
pubmed: 12824425
J Recept Signal Transduct Res. 2016 Oct;36(5):478-87
pubmed: 26754208
J Clin Invest. 2011 Apr;121(4):1657-66
pubmed: 21383503
J Intern Med. 2006 Apr;259(4):381-92
pubmed: 16594906
Medicine (Baltimore). 2022 Jul 1;101(26):e29703
pubmed: 35777030
Swiss Med Wkly. 2015 Jul 28;145:w14154
pubmed: 26218664
G3 (Bethesda). 2019 May 7;9(5):1303-1311
pubmed: 30858237
Physiol Genomics. 2009 Aug 7;38(3):319-27
pubmed: 19509081
Circ Res. 2014 Feb 14;114(4):660-71
pubmed: 24300334
Lab Anim (NY). 2011 May;40(5):155-60
pubmed: 21508954
Physiology (Bethesda). 2009 Feb;24:45-57
pubmed: 19196651
Genetics. 2020 Dec;216(4):905-930
pubmed: 33067325
Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3380-5
pubmed: 12612341
J Cell Physiol. 2019 Nov;234(11):20432-20442
pubmed: 31012109
Microcirculation. 2010 Jul;17(5):333-47
pubmed: 20618691
Trends Genet. 2019 Jul;35(7):501-514
pubmed: 31133439
Am J Physiol Heart Circ Physiol. 2009 Jun;296(6):H1907-13
pubmed: 19395551
J Mol Cell Cardiol. 2010 Aug;49(2):251-9
pubmed: 20346953
PLoS Biol. 2010 Jun 29;8(6):e1000412
pubmed: 20613859
Circ Res. 2020 Jul 3;127(2):310-329
pubmed: 32833569
Front Physiol. 2021 Aug 19;12:720672
pubmed: 34489737
J Mol Cell Cardiol. 2015 Oct;87:4-16
pubmed: 26254180
Methods Mol Biol. 2019;1950:143-163
pubmed: 30783972
Physiol Genomics. 2007 Jul 18;30(2):179-91
pubmed: 17426116
Stroke. 2022 Oct;53(10):3222-3234
pubmed: 35938420
J Biol Chem. 2019 Dec 6;294(49):18571-18585
pubmed: 31636120
Nature. 2002 Dec 5;420(6915):574-8
pubmed: 12466852
Transl Stroke Res. 2017 Jun;8(3):273-283
pubmed: 27844273
PLoS One. 2012;7(3):e31910
pubmed: 22412848
J Mol Cell Cardiol. 2021 Jan;150:1-11
pubmed: 33038388
J Cereb Blood Flow Metab. 2021 Sep;41(9):2311-2328
pubmed: 33715494
Physiol Genomics. 2010 Aug;42(3):469-79
pubmed: 20551146
J Cereb Blood Flow Metab. 2021 Apr;41(4):731-744
pubmed: 32703056
Circulation. 2013 Aug 13;128(7):737-44
pubmed: 23817577
PLoS One. 2012;7(10):e46688
pubmed: 23056405
Genetics. 2019 Nov;213(3):1079-1092
pubmed: 31488517
Biochem J. 2003 May 1;371(Pt 3):973-80
pubmed: 12564955
Med One. 2019;4:
pubmed: 31840083
Radiol Clin North Am. 2023 May;61(3):435-443
pubmed: 36931760
Circ Res. 2009 Jul 2;105(1):89-98
pubmed: 19478202
Genetics. 2017 Jun;206(2):537-556
pubmed: 28592495
Neuropharmacology. 2018 May 15;134(Pt B):280-292
pubmed: 28801174
Genetics. 2017 Jun;206(2):557-572
pubmed: 28592496
J Vasc Res. 1996 Nov-Dec;33(6):480-8
pubmed: 8998197
Circ Res. 2012 Dec 7;111(12):1539-50
pubmed: 22965144
Tissue Eng Part A. 2011 Mar;17(5-6):617-29
pubmed: 20874260
Elife. 2020 May 18;9:
pubmed: 32420870
Int J Mol Sci. 2022 Mar 31;23(7):
pubmed: 35409246
Int J Mol Sci. 2019 Jul 24;20(15):
pubmed: 31344780
Stroke. 2019 Apr;50(4):867-872
pubmed: 30908160
J Cereb Blood Flow Metab. 2020 Sep;40(9):1806-1822
pubmed: 32423327
J Stroke Cerebrovasc Dis. 2018 May;27(5):1237-1251
pubmed: 29337049
PLoS One. 2014 Mar 31;9(3):e93494
pubmed: 24686421
Cell. 2019 Feb 21;176(5):1128-1142.e18
pubmed: 30686582
Stroke. 2020 May;51(5):1493-1502
pubmed: 32279619
Ann Transl Med. 2022 Sep;10(18):982
pubmed: 36267780
Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9734-9
pubmed: 15210992

Auteurs

James E Faber (JE)

Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, NC, USA.
Curriculum in Neuroscience, University of North Carolina, Chapel Hill, NC, USA.
McAllister Heart Institute, University of North Carolina, Chapel Hill, NC, USA.

Hua Zhang (H)

Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, NC, USA.

James G Xenakis (JG)

Department of Genetics, University of North Carolina, Chapel Hill, NC, USA.

Timothy A Bell (TA)

Department of Genetics, University of North Carolina, Chapel Hill, NC, USA.

Pablo Hock (P)

Department of Genetics, University of North Carolina, Chapel Hill, NC, USA.

Fernando Pardo-Manuel de Villena (F)

Department of Genetics, University of North Carolina, Chapel Hill, NC, USA.
Carolina Institute for Developmental Disabilities, University of North Carolina, Chapel Hill, NC, USA.
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.

Martin T Ferris (MT)

Department of Genetics, University of North Carolina, Chapel Hill, NC, USA.

Wojciech Rzechorzek (W)

Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, NC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH